EUVIMEDEUVIMED entdecken
Multizentrische Studie

Clinical profiling and outcomes of ischaemic stroke patients with immune thrombocytopenia: A multicentre retrospective study

LiQin Cao, Jin Wu, ZhuoYu An, Fan Zhou, DengJu Li, LiLi Ji, YuPing Gong, ZhuoRuoHan Yu, KaiTeng Cai, GuoYang Zhang, YanYan Xie, ZePing Zhou und 13 weitere

British Journal of Haematology · 2026-07 · 209 (1) · 228-239

DOI: 10.1111/bjh.70572 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift British Journal of Haematology, online erschienen am 01.06.2026. Verfasst von LiQin Cao und 24 weiteren Autor:innen. Beteiligte Einrichtung: Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Ischemic Stroke. Die Arbeit nennt 58 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Beijing Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To investigate the risk factors, treatment strategies and prognosis in patients with acute ischaemic stroke (AIS) after immune thrombocytopenia (ITP), we conducted a multicentre case–control study. One hundred and thirteen adult ITP patients with AIS were included, and each ITP‐AIS was paired with three control subjects. The ITP‐AIS cohort had a median age of 65 (24–97) years, was predominately female (61 vs. 52) and had a median platelet count of 44 × 10 9 /L (range: 4–355 × 10 9 /L) at the time of AIS. Post‐infarction treatment included anti‐platelet therapy ( n = 36, 31.9%), anti‐coagulation therapy ( n = 4, 3.5%), combined anti‐platelet–anti‐coagulation therapy ( n = 4, 3.5%) and endovascular thrombectomy ( n = 1, 0.9%). Haemorrhagic transformation occurred in 5 (4.4%) patients. Three patients (2.7%) died due to intracranial haemorrhage, gastrointestinal haemorrhage or severe pulmonary infection. Multivariate analysis revealed that age greater than 60 years ( p < 0.001; odds ratio [OR] 3.12; 95% confidence interval [CI] 1.82–5.37), diabetes mellitus ( p = 0.018; OR 1.99; 95% CI 1.13–3.52), hypertension ( p < 0.001; OR 2.75; 95% CI 1.62–4.66), renal failure ( p = 0.036; OR 3.00; 95% CI 1.08–8.38), smoking ( p < 0.001; OR 5.02; 95% CI 2.31–10.88) and hyper‐low‐density lipoprotein (LDL)‐C ( p = 0.02; OR 2.34; 95% CI, 1.14–4.78) were independent risk factors for AIS after ITP. This study revealed that ITP‐related treatments might not increase the risk of ITP‐AIS. The management of ITP‐AIS patients requires close collaboration between haematologists and vascular neurologists to carefully balance therapeutic benefits against the risk of haemorrhagic complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purpura, Thrombocytopenic, IdiopathicIschemic StrokeHumansFemaleMiddle AgedAgedRetrospective StudiesMaleAdultAged, 80 and overRisk FactorsCase-Control StudiesYoung AdultTreatment OutcomePrognosis

Stichwörter der Autor:innen

acute ischaemic strokeimmune thrombocytopenia

Autor:innen und Institutionen

  • Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
  • Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
  • Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Second Affiliated Hospital, Kunming Medical University, Kunming, China.
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

ORCID-Profile: YunFeng Cheng, Ying Lu, HaiXia Fu, XiaoHui Zhang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Beijing Natural Science Foundation
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Cao, L., Wu, J., An, Z., Zhou, F., Li, D., Ji, L., Gong, Y., Yu, Z., Cai, K., Zhang, G., Xie, Y., Zhou, Z., Cheng, Y., Lu, Y., Cheng, P., Ma, L., Yan, Z., Fu, H., Zhu, X., …, & Zhang, X. (2026). Clinical profiling and outcomes of ischaemic stroke patients with immune thrombocytopenia: A multicentre retrospective study. British Journal of Haematology, 209(1), 228-239. https://doi.org/10.1111/bjh.70572

Vancouver

Cao L, Wu J, An Z, Zhou F, Li D, Ji L, et al. Clinical profiling and outcomes of ischaemic stroke patients with immune thrombocytopenia: A multicentre retrospective study. British Journal of Haematology. 2026;209(1):228-239. doi:10.1111/bjh.70572

BibTeX
@article{Cao2026,
  author = {Cao, LiQin and Wu, Jin and An, ZhuoYu and Zhou, Fan and Li, DengJu and Ji, LiLi and Gong, YuPing and Yu, ZhuoRuoHan and Cai, KaiTeng and Zhang, GuoYang and Xie, YanYan and Zhou, ZePing and Cheng, YunFeng and Lu, Ying and Cheng, Peng and Ma, LiPing and Yan, ZhenYu and Fu, HaiXia and Zhu, XiaoLu and Huang, QiuSha and He, Yun and Zhao, XiangYu and Chang, YingJun and Huang, XiaoJun and Zhang, XiaoHui},
  title = {Clinical profiling and outcomes of ischaemic stroke patients with immune thrombocytopenia: A multicentre retrospective study},
  journal = {British Journal of Haematology},
  year = {2026},
  volume = {209},
  number = {1},
  pages = {228--239},
  doi = {10.1111/bjh.70572}
}
Kostenlos starten →